Athira Pharma (ATHA)
(Delayed Data from NSDQ)
$2.64 USD
+0.08 (3.13%)
Updated May 24, 2024 04:00 PM ET
After-Market: $2.65 +0.01 (0.38%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-0.75 | 0.00% |
Earnings Summary
For their last quarter, Athira Pharma (ATHA) reported earnings of -$0.69 per share, beating the Zacks Consensus Estimate of $-0.80 per share. This reflects a positive earnings surprise of 13.75%. Look out for ATHA's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.75 per share, reflecting a year-over-year increase of 3.85%.
Earnings History
Price & Consensus
Zacks News for ATHA
Is Arcutis Biotherapeutics (ARQT) Outperforming Other Medical Stocks This Year?
ATHA: What are Zacks experts saying now?
Zacks Private Portfolio Services